Quotient Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Quotient Wealth Partners’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$444K	Buy	995 +81	+9%	+$37.8K	0.01%	215
2025 Q4	$414K	Sell	914 -12	-1%	-$5.17K	0.01%	228
2025 Q3	$363K	Sell	926 -145	-14%	-$60.6K	0.01%	246
2025 Q2	$477K	Sell	1,071 -59	-5%	-$27.2K	0.01%	196
2025 Q1	$548K	Buy	1,130 +149	+15%	+$69.4K	0.02%	164
2024 Q4	$395K	Sell	981 -6	-0.6%	-$2.78K	0.01%	203
2024 Q3	$459K	Sell	987 -12	-1%	-$5.76K	0.02%	181
2024 Q2	$468K	Buy	999 +153	+18%	+$66.4K	0.02%	180
2024 Q1	$354K	Sell	846 -93	-10%	-$39.3K	0.01%	209
2023 Q4	$382K	Buy	+939	New	+$347K	0.01%	203

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Quotient Wealth Partners's VRTX Position: Q1 2026 in Review

Quotient Wealth Partners increased its Vertex Pharmaceuticals (VRTX) stake by 8.9% in Q1 2026, buying an estimated $37.8K and bringing the position to 995 shares worth $444K. The position accounts for 0.01% of the portfolio, ranked #215.

Quotient Wealth Partners first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. The position peaked at $548K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Quotient Wealth Partners held 995 shares of Vertex Pharmaceuticals worth $444K as of Q1 2026.
Quotient Wealth Partners bought 81 Vertex Pharmaceuticals shares in Q1 2026, an estimated $37.8K.
Vertex Pharmaceuticals made up 0.01% of Quotient Wealth Partners's portfolio in Q1 2026, its #215 holding.
Quotient Wealth Partners first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
Quotient Wealth Partners's Vertex Pharmaceuticals position peaked at $548K in Q1 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Quotient Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.